Think of GHRH as a messenger that tells your pituitary gland (a small gland in your brain) to make and release more growth hormone
As a result, people tend to eat less and have fewer food cravings while taking them
The medical community began noticing unusual patterns of vision loss among their patients using semaglutide medications, particularly cases of NAION that seemed to occur at higher rates than expected in the general population
Beyond the reduction in energy intake, co-agonism seems to be able to affect food choice, favoring the consumption of healthy nutrients, how documented in experiments on mice and rats (67)
Cadmium may accentuate inflammatory processes, which may in turn disrupt the HPA axis and trigger symptoms of ME/CFS (161, 162)
Additional safety considerations include: Cardiovascular risk: Both medications require caution in patients with cardiovascular disease